Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLOPCI
NCT07164859Phase 3Recruiting
- Start
- Mar 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin, ticagrelor, prasugrel, clopidogrel in coronary artery disease (CAD). Started Mar 2026; status: recruiting.
02
Drugs
aspirinticagrelorprasugrelclopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07164859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07164859.